Key Takeaways
- • Cerebras Systems filed for IPO on Nasdaq under ticker CBRS with a $23 billion current valuation and reported $35 billion target valuation, aiming eventually for a $250 billion valuation per its prospectus.
- • The AI chipmaker reported $510 million in 2025 revenue, representing 76% year-over-year growth, with a $24.6 billion backlog in remaining performance obligations as of December 31, 2025.
- • Key investors Benchmark, Foundation Capital, and Eclipse are positioned to benefit significantly from the IPO, with Benchmark investing at least $225 million through special-purpose vehicles and Eclipse having recently raised $1.3 billion across two new funds.
- • Cerebras secured a $20 billion contract with OpenAI that could potentially dwarf current annual revenue; OpenAI has already accessed approximately one-sixth of a potential 10% equity stake through a $1 billion loan agreement.
- • The company swung from a $481 million net loss to $87.9 million in net income, addressing prior investor concerns about revenue concentration in Abu Dhabi through diversified contracts with OpenAI and Amazon AWS; Morgan Stanley, Citigroup, Barclays, and UBS are leading underwriters.
Summary
Cerebras Systems, an inference chipmaker valued at $23 billion, filed for its second IPO attempt on Friday, marking a significant milestone in the generative AI infrastructure sector. The company's Nasdaq filing under ticker CBRS follows its withdrawal of a 2024 prospectus filing. According to the IPO filing, Cerebras reported $510 million in revenue for 2025—a robust 76% increase from the prior year—alongside a dramatic swing to $87.9 million in net income compared to a $481 million net loss previously. The company carries a $24.6 billion backlog in remaining performance obligations, positioning it as a substantial beneficiary of continued AI infrastructure demand.
The IPO carries significant implications for leading venture investors. Benchmark Capital has invested at least $225 million in Cerebras through two special-purpose vehicles designated "Benchmark Infrastructure." Foundation Capital and Eclipse, both early backers, stand to realize substantial returns should the offering succeed. Eclipse, which holds a position in the company, recently closed $1.3 billion across two new funds (Eclipse Fund VI at $720 million and Early Growth Fund III at $591 million), signaling continued conviction in AI infrastructure investments. CEO Andrew Feldman and CTO Sean Lie have structured share payouts contingent on Cerebras reaching $75 billion, $150 billion, and $250 billion in average valuation within nine years—a structure that aligns founder incentives with significant value creation targets.
Cerebras' differentiated technology and customer base provide fundamental support for its valuation. The company's Wafer-Scale Engine processor represents a unique architectural approach: a single-wafer design measuring 46,225 square millimeters with 4 trillion transistors and 900,000 cores. This contrasts sharply with industry standards using thousands of small GPUs clustered together. The company has secured prominent customers including Argonne National Laboratory and GlaxoSmithKline, with revenue increasingly diversified beyond the Abu Dhabi concentration that troubled previous investors.
The OpenAI relationship warrants particular attention for investors analyzing concentration risk and upside potential. Cerebras has secured a $20 billion contract with OpenAI, which could eventually dwarf current annual revenue. The structure grants OpenAI access to approximately one-sixth of a potential 10% equity stake through a $1 billion loan agreement already deployed. An additional 17% of the stake vests if Cerebras maintains a $40 billion average valuation for one month—a threshold near the company's reported $35 billion IPO target. OpenAI gains remaining stake access upon full purchase of 2GW of inference compute capacity. This arrangement mirrors OpenAI's similar deal with AMD, which included up to 10% equity contingent on GPU delivery and AMD share price reaching $600.
The IPO timing reflects favorable market conditions and reduced competition for capital. With Morgan Stanley, Citigroup, Barclays, and UBS leading underwriting, Cerebras appears positioned as the potential first major venture-backed AI infrastructure IPO of the generative era. Prediction market odds reflect 90% conviction in a Cerebras IPO before 2027, underscoring institutional confidence in the deal's execution.
The IPO carries significant implications for leading venture investors. Benchmark Capital has invested at least $225 million in Cerebras through two special-purpose vehicles designated "Benchmark Infrastructure." Foundation Capital and Eclipse, both early backers, stand to realize substantial returns should the offering succeed. Eclipse, which holds a position in the company, recently closed $1.3 billion across two new funds (Eclipse Fund VI at $720 million and Early Growth Fund III at $591 million), signaling continued conviction in AI infrastructure investments. CEO Andrew Feldman and CTO Sean Lie have structured share payouts contingent on Cerebras reaching $75 billion, $150 billion, and $250 billion in average valuation within nine years—a structure that aligns founder incentives with significant value creation targets.
Cerebras' differentiated technology and customer base provide fundamental support for its valuation. The company's Wafer-Scale Engine processor represents a unique architectural approach: a single-wafer design measuring 46,225 square millimeters with 4 trillion transistors and 900,000 cores. This contrasts sharply with industry standards using thousands of small GPUs clustered together. The company has secured prominent customers including Argonne National Laboratory and GlaxoSmithKline, with revenue increasingly diversified beyond the Abu Dhabi concentration that troubled previous investors.
The OpenAI relationship warrants particular attention for investors analyzing concentration risk and upside potential. Cerebras has secured a $20 billion contract with OpenAI, which could eventually dwarf current annual revenue. The structure grants OpenAI access to approximately one-sixth of a potential 10% equity stake through a $1 billion loan agreement already deployed. An additional 17% of the stake vests if Cerebras maintains a $40 billion average valuation for one month—a threshold near the company's reported $35 billion IPO target. OpenAI gains remaining stake access upon full purchase of 2GW of inference compute capacity. This arrangement mirrors OpenAI's similar deal with AMD, which included up to 10% equity contingent on GPU delivery and AMD share price reaching $600.
The IPO timing reflects favorable market conditions and reduced competition for capital. With Morgan Stanley, Citigroup, Barclays, and UBS leading underwriting, Cerebras appears positioned as the potential first major venture-backed AI infrastructure IPO of the generative era. Prediction market odds reflect 90% conviction in a Cerebras IPO before 2027, underscoring institutional confidence in the deal's execution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.